Geneva has received a substantial, albeit limited, supply (500 doses) of the inactivated (injection-type) H1N1 Influenza vaccine. Click here for the official description of the vaccine from the CDC. You may also find more information at the CDC web site.
We are currently planning a general distribution for this coming Friday (as it happens, Friday the 13th). In the meantime, persons in the Geneva community who are (1) pregnant or who think that they might be pregnant, (2) who desire to have the vaccine, and (3) have at least verbal permission from their personal obstetrician may report to the infirmary anytime tomorrow (Thursday) between 7 a.m. and 2 p.m. to receive the vaccine. All three of these criteria must be met.
On Friday, we will begin distributing the vaccine to students and employees according to the following plan in Skye Lounge.
Within these parameters, we will administer the vaccine on a first come, first serve basis. If the supply does not last through the day, we will send a general campus e-mail notifying you of that fact.
The following information may answer some of the questions that you have.
Undoubtedly, there will be difficulties along the way. Thank you for your patience and cooperation as we move through this very unusual situation.
Provost and Professor of Psychology
For the second year in a row, Geneva’s ABET-accredited engineering program placed in U.S. News & World Report’s Top 100 Best Undergraduate Engineering Programs in the nation.